The narrative is shifting. Or at least, the algorithm thinks it is.
In May 2025, the Department of Health and Human Services dropped a bombshell. Robert F. Kennedy Jr.’s “Make America Healthy Again” Commission released a report titled “The Overmedicalization of Our Kids.” It was controversial, yes. But it wasn’t the only thing rattling cages. Kennedy has long been vocal about his disdain for conventional psychiatry. He’s blamed antidepressants for mass shootings. He claims we are all “poisoned” by stimulants like Adderall and Vyvanse, drugs designed to treat ADHD.
Now, while the government moves to restrict access to these very medications, a different kind of industry is booming.
Wellness influencers are flooding TikTok and Instagram. They are selling a cure. Or rather, they are selling a feeling. Calmness. Mental clarity. Emotional balance. The catch? These aren’t prescribed drugs. They are unregulated dietary supplements.
Brands like Graymatter Labs, Stasis, MagicMind, Thesis, and Nello are paying creators to swap their prescription bottles for nootropic pills. The pitch is seductive. Stimulants are described as jittery, disruptive, and dangerous. The alternatives? Natural. Gentle. “Biohacked.”
But there is a problem. The Food and Drug Administration doesn’t review these supplements before they hit shelves. They don’t have to prove safety or efficacy. Yet, influencers are marketing them as viable, and often superior, replacements for life-altering medication.
The Influencer Sales Pitch
The ads are everywhere. You’ve seen them.
Katie Silbar, a content creator, put it plainly in a March video. She spent years on Adderall. In college. Through her late twenties. Then, she stopped. Why?
“I decided I didn’t want to be on a Stimulant anymore.”
She switched to Thesis, a supplement company selling pill bundles for $59 a jar. Silbar says the shift was immediate. Less jittery. More focused. The focus, she notes, “isn’t forced.” Would she pay more? She says she’d gladly pay double.
It’s a compelling story. It’s also dangerous misinformation if presented as medical advice.
Other brands play harder on the fear factor. MagicMind features comedian Pete Holmes and NFL star Matthew Stafford. Their videos depict Adderall as inherently addictive. They aren’t entirely wrong. Stimulants are Schedule II controlled substances because of misuse potential. But medical experts emphasize a critical distinction: taken under supervision, these drugs are safe and effective for treating ADHD.
Graymatter Labs takes it further. A father claims his “Bright Mind” drink mix cured the mood swings caused by his son’s Adderall. The result? More patience. More calm. The ingredient list includes ashwagandha, turmeric B vitamins, and 27 other plant-based nootropics.
None of these companies responded to WIRED’s requests for comment. Their scientific claims? Untouched. Their potential risk in steering vulnerable patients away from treatment? Ignored.
The Platform Disconnect
Meta and TikTok did not comment on the record. However, a spokesperson for Meta confirmed that several brand accounts were taken down for health misinformation.
YouTube is different. Boot Bullwinkle, a spokesperson, stated that the same accounts on YouTube violated no guidelines. The platform allows the content to stay up.
Meanwhile, Takeda Pharmaceuticals, makers of Vyvanse and extended-release AdderAll, offered a standard deflection. Decisions, they said, must be made by a treating health care provider. A polite way of saying, “Don’t listen to TikTok.”
The Crisis of Access and Exploitation
Why now? Why is this messaging so resonant?
Because many people can’t get their meds.
US pharmacies have faced chronic shortages of Adderall, Vyvanse (Vyvanse), Ritalin, and Concerta (Concerta) since 2022. The Drug Enforcement Administration increased production quotas in the fall. It didn’t fix the bottlenecks. Supply issues persist.
Cindy Goldrich, an ADHD coach and mental health counselor in Boulder, calls this landscape “exploitative.” When you are desperate for a prescription that doesn’t exist, and a brand offers a “gentle” alternative on your feed, the temptation is overwhelming.
“It’s selling to people in crisis,” Goldrich says. “Who are scared and out of options through a systemic failure that has nothing to do with whether the medication works.”
Stasis, for example, markets itself as a complement to ADHD medication. Its ads are subtler. They promise to fix the “afternoon crash.” The 3:47 pm irritability. The brain fog. The guilt of snapping at your kids.
“Gentle reminder that if Addlerall has you crashing at 3:47 pm… scientists at Yale created Stasis.”
It sounds reasonable. Until you realize it portrays the actual medication as insufficient.
The Stigma of Science
This marketing strategy does more than just sell supplements. It deepens stigma.
Kristen Leinung, a psychiatric nurse practitioner in Portland, notes that stimulant medications have existed for nearly 100 years. They have been approved for children since the 1960. The side effects are known. They are predictable. They are studied.
“These ads do further that stigma,” Leinung says.
The danger is real. Untreated ADHD carries a high risk of mortality. It doubles the risk of premature death. It is linked to risky driving, poor sleep, substance abuse, and lower life expectancy. Encouraging people to stop or avoid medication based on an influencer’s testimonial isn’t just bad advice. It’s a public health risk.
Andrew Kahn, a psychologist at Understood.org, highlights the regulatory void. Supplements do not have to prove safety or effectiveness to the FDA. Yet, they claim benefits equal to medication.
“People are wary of big Pharma. A ‘natural’ option feels safer, even when it isn’t better tested.”
The Bigger Picture
Robert F. Kennedy Jr.’s influence cannot be ignored here. He swears by methylene blue. He champions fringe products. By positioning himself as the authority on “overmedicalization,” he normalizes the idea that psychiatric drugs are the enemy.
HHS press secretary Emily Hilliard stated that the department is embedding “informed consent, transparency, and evidence-based alternatives” into federal policy. But “evidence-based alternatives” to Adderall? That evidence is thin.
Common ingredients in these nootropics—omega-3s, L-theanine, certain adaptogens—have modest research behind them. They might support mood. They might help focus. But they are not Adderall. They cannot treat severe ADHD symptoms with the same efficacy.
And even if you use supplements, medication or natural remedies don’t teach you how to live with the condition.
Goldrich points out the missing piece. Whether you take a pill or a powder, you still need to learn skills. Planning. Emotional regulation. Coping strategies.
“Whether a person takes medication or supplements or both,” Goldrich says, “they still need to learn those skills.”
So where does that leave you?
If you are considering stopping your prescribed stimulants, Kristen Leinung urges caution. Think twice. That video on your phone is not a doctor. The algorithm doesn’t care about your mortality risk. It cares about engagement.
Have a thorough discussion with your health care provider. Before you make any changes.
